Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L5 pseudogene 17 (RPL5P17)
- Target
- RPL5P17
- Molecular classification
- Other (pseudogene)
01
Overview
Ribosomal protein L5 pseudogene 17 (RPL5P17) is a processed, non-functional pseudogene related to the ribosomal protein L5 gene. It shares sequence similarity with the functional RPL5 gene but does not encode a protein product. Pseudogenes like RPL5P17 are distributed through the genome as remnants of gene duplication or retrotransposition events and are not expressed as functional molecules. While RPL5 is implicated in ribosome formation and certain disease states, RPL5P17 is not a drug target and has no known biological or clinical relevance.
- Other names
- RPL5_8_591RPL5P17
02
Mechanism of action
None, since there is no encoded protein or active biological entity
03
Biological functions
None specifically attributed; pseudogenes do not typically have recognized biological functions. Any functional role would be atypical and undocumented for RPL5P17
04
Disease associations
None. There is no evidence linking RPL5P17 to disease roles, unlike the protein-coding RPL5 gene
05
Safety considerations
None described. Pseudogenes do not typically raise safety or therapeutic concerns
06
Interacting drugs
None known, as it does not encode a protein that can interact with drugs
07
Biomarkers
None. Pseudogenes are not typically used as biomarkers; RPL5P17 specifically has no documented biomarker use
Beyond the preview
Go deeper on Ribosomal protein L5 pseudogene 17 (RPL5P17).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L5 pseudogene 17 (RPL5P17).